Scholars Central

Mini reviewPublished 10 Nov 2016

Evaluation of Fluoride-18-Labeled Boronophenylalanine-Positron Emission Tomography Imaging for the Assessment of Boron Neutron Capture Therapy in Patients with Recurrent Head and Neck Squamous Cell Carcinoma

Authors: Teruhito Aihara, Jyunichi Hiratsuka, Nobuyoshi Fukumitsu, Hitoshi Ishikawa, Norimasa Morita, Hiroaki Kumada, Nobuhiko Kamitani, Kayoko Ohnishi, Minoru Suzuki, Hideyuki Sakurai, Tamotsu Harada

1Proton Medical Research Centre, University of Tsukuba, Tsukuba, Japan; 2Department of Otolaryngology Head and Neck Surgery, Kawasaki Medical School, Kurashiki, Japan; 3Department of Radiation Oncology, Kawasaki Medical School, Kurashiki, Japan; 4Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, Japan

Otolaryngology: Open Access

Volume 6 · Issue 6 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: A role for fluoride-18-labeled boronophenylalanine positron emission tomography (18FBPA-PET) in boron neutron capture therapy (BNCT) has not been fully elucidated. We investigated the role of 18FBPA-PET in BNCT for recurrent head and neck squamous cell carcinoma (HNSCC) patients. Materials and methods: 18FBPA-PET images were obtained from 10 histologically verified recurrent HNSCC patients who received BNCT. The intratumoral accumulation of 18FBPA was calculated as the ratio of maximum and minimum radioactivity counts to that of normal tissue (Tmax/N and Tmin/N ratios, respectively). The percentage volume at which the radioactivity count ratio was >2.5 compared to normal tissue was also calculated (Vo2.5). Moreover, mean and minimum irradiation dose to the tumor was calculated. We investigated which parameters could predict the treatment effect of BNCT. Results: Treatment effects of local lesions were as follows: complete remission (CR) in 5 cases and non-CR in 5 cases. Only Tmin/N ratio showed a significant difference between the CR and non-CR groups (P=0.008). Conclusion: The Tmin/N ratio of 18FBPA-PET can predict the treatment effect of BNCT for recurrent HNSCC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Otolaryngology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOtolaryngology: Open Access
  • SubjectENT & Otolaryngology
  • BylineArticles whose byline prints “Teruhito Aihara”
  • BylineArticles whose byline prints “Jyunichi Hiratsuka”
  • BylineArticles whose byline prints “Nobuyoshi Fukumitsu”
  • BylineArticles whose byline prints “Hitoshi Ishikawa”
  • BylineArticles whose byline prints “Norimasa Morita”
  • BylineArticles whose byline prints “Hiroaki Kumada”
  • BylineArticles whose byline prints “Nobuhiko Kamitani”
  • BylineArticles whose byline prints “Kayoko Ohnishi”